US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Green Oleo SpA (GRN) 銘柄情報

Green Oleo SpA (GRN)

0.424

-0.016

(-3.64%)

終了 7月12日 12:30AM

Green Oleo SpA (GRN) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.424

( -3.64% )

買値

0.42

売値

0.47

出来高

22,500

平均取引量 (3 か月)

14,838 €

財務取引量

-

0.424 日の範囲 0.442

0.42 52 週間の範囲 0.845

時価総額

企業価値

26.972M

前日終値

0.44

始値

0.442

時刻

最終取引時間

VWAP

-

歳入

70.61M

純利益

-2.77M

発行済株式数

31,807,000

浮動株比率 (%)

78.87%

機関投資家保有比率 (%)

-

配当利回り

PER

-5.17

株価売上高倍率 (PSR)

0.2

1 株当たり利益 (EPS)

-0.09

ベータ

0.07

Green Oleo S.p.A. produces and sells fine oleochemicals from renewable raw materials. The company offers esters, fatty acids, glycerines, oleic acids, soaps, stearic acids, and other products. It serves adhesives, agriculture, candles, detergents, intermediate products for industry, lubricants, pape... Green Oleo S.p.A. produces and sells fine oleochemicals from renewable raw materials. The company offers esters, fatty acids, glycerines, oleic acids, soaps, stearic acids, and other products. It serves adhesives, agriculture, candles, detergents, intermediate products for industry, lubricants, paper, personal care, plastic and elastomers, resins and paints, textiles and leather, and other market sectors.Green Oleo S.p.A. is based in Cremona, Italy. 詳細を表示

セクター

Materials

業界

Chemicals

ウェブサイト

www.greenoleo.com

本社

Cremona, Italy

設立

-

Green Oleo SpA is listed in the Materials sector of the イタリア証券取引所 with ticker GRN. The last closing price for Green Oleo was 0.44 €. Over the last year, Green Oleo shares have traded in a share price range of 0.42 € to 0.845 €.

Green Oleo currently has 31,807,000 shares in issue. The market capitalisation of Green Oleo is 13.49 € million. Green Oleo has a price to earnings ratio (PE ratio) of -5.17.

American Stock Exchange Launches Four New Claymore ETFs

NEW YORK, Dec. 15 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today announced that it has launched trading in four new exchange...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.066	-13.4693877551	0.49	0.49	0.42	43500	0.44903448	DE
4	-0.156	-26.8965517241	0.58	0.595	0.42	21075	0.48672598	DE
12	-0.206	-32.6984126984	0.63	0.705	0.42	12311	0.5355977	DE
26	-0.236	-35.7575757576	0.66	0.75	0.42	11259	0.57816998	DE
52	-0.411	-49.2215568862	0.835	0.845	0.42	11091	0.65803898	DE
156	-1.126	-72.6451612903	1.55	1.56	0.42	17729	0.94525318	DE
260	-1.126	-72.6451612903	1.55	1.56	0.42	17729	0.94525318	DE

GRN - Frequently Asked Questions (FAQ)

What is the current Green Oleo SpA share price?

The current share price of Green Oleo SpA is 0.424 €

How many Green Oleo SpA shares are in issue?

Green Oleo SpA has 31,807,000 shares in issue

What is the market cap of Green Oleo SpA?

The market capitalisation of Green Oleo SpA is EUR 13.49M

What is the 1 year trading range for Green Oleo SpA share price?

Green Oleo SpA has traded in the range of 0.42 € to 0.845 € during the past year

What is the PE ratio of Green Oleo SpA?

The price to earnings ratio of Green Oleo SpA is -5.17

What is the cash to sales ratio of Green Oleo SpA?

The cash to sales ratio of Green Oleo SpA is 0.2

What is the registered address of Green Oleo SpA?

The registered address for Green Oleo SpA is Via Bergamo, 66, Cremona, Cremona, 26100

What is the Green Oleo SpA website address?

The website address for Green Oleo SpA is www.greenoleo.com

Which industry sector does Green Oleo SpA operate in?

Green Oleo SpA operates in the Chemicals sector

sharkey1

sharkey1 5分前

And so does Kirko.

wadegarret

wadegarret 5分前

Best year 2009 up 580%- This year up 290% so far

That is, in my real portfolio. Sometimes Wadegarret portfolio performs better, and sometime worse, as I do more trading in my real portfolio. Gernerally speaking I play the same stocks, but sometimes I do a lot more trading in my

Nightdaytrader

Nightdaytrader 7分前

They better do it before October elections because if Dems win, nothing will happen and then in January, 2027, I think Maxine Waters will take over House Banking Committee that oversees FDIC.

Baxers

If they had disclosed then the other side would have had a runaway field day on the information and the stock price would be even further in bits and raising capital would be even more difficult that it already is. Entirely unsurprised that (if my idea is correct) they didn't disclose. Caught betwee

Goats'nCrows

Goats'nCrows 8分前

LC, I have been paying attention, and I have been reading your stances. I mean no offense or attack but I can no more believe that you are spending Saturday to selflessly convince shareholders to save themselves/the company than I can believe the "Cofer is under your bed" crowd.

Ar

learningcurve2020

learningcurve2020 10分前

So what’s Advent doing with 85 employees and about $30M in revenues back in 2024? Plus they have the business and Cognate / River to hold their hand. My belief is they already pivoted as you can see by Advent’s website.

Nemesis18

Nemesis18 15分前

I didn't feel that I needed to answer, but
if the MHRA or FDA issues a definitive rejection or demands a completely new Phase III trial, due to the trial's controversial external-control design, NWBO's valuation will face an existential threat.
Without DCVax-L approval, they would b

kenjiroo

kenjiroo 15分前

I hope I can still spin my head at old age !! Cant wait forever 😜

learningcurve2020

learningcurve2020 17分前

If you were at all paying attention my stance has always been to get off your sheepish butts before it’s too late to 1) force new management 2) claw back Advent 3) get the CDMO up and running! Somehow 2 was achieved but sneakily without the revenues, sadly.

Steady_T

Steady_T 17分前

Wouldn't ADVENT be a wholly owned subsidiary?

CryptoRain

CryptoRain 18分前

Yes it does but those holding through the Jan 5 ex date and then sold will most likely get it too. This company is doing things right

kspar1

kspar1 18分前

https://www.patreon.com/posts/163510848

Impressions on The CHMP Blarcamesine Rejection Justification"

Upbeat re-visit of the CHMP conclusion by Bio_Oko. Basically, he observes that Anavex was trying to get those folks to see the goodness in the numbers, hoping they'd i

Lime Time

Lime Time 19分前

Yeah forgot about this one. Bigtime scam in the past. They used to advertise on iHub. Really good share structure. Will check it out. They put it in the time capsule in 2023. Someone gotta open it up some day

boston745

boston745 19分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

boston745

boston745 19分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

Jetmek_03052

Jetmek_03052 20分前

As usual, you are wrong.

I never said I was an "expert" on DBMM's financial reports. I said I had forecast DBMM's revenues pretty accurately. And my past posts about them have been proven to be just that.

Where did I say I was an "expert"? Sounds like your opinion a

Steady_T

Steady_T 20分前

$.17 is proof that the drug has not been approved in 923 days.

The jury i.e. MHRA is still out on whether the drug works or not.

Any other conclusion is based on wishful thinking.

Bizreader

Bizreader 21分前

Yep and let's see what happens going forward giving the current state of affairs. Maybe a pendulum or whiplash experience may be next up giving patterns of history.

larrybaz

larrybaz 21分前

Thanks for all the hard work, SSKILLZ. Should be an interesting contest. I'll be interested to see how the indices fare. We will find out if our collective stock-picking ability paints us as contenders or pretenders!

02opida

02opida 21分前

Recent Trades -
Time ET Ex Price Change Volume
15:36:59 Q 0.0071 0.0008 200,000
15:30:40 Q 0.0071 0.0008 13,579
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
1

randomwalk007

randomwalk007 22分前

The reason it’s taken so long is BIOAQ had to wait until CERN was shut down to close off the parallel universe and enable the completion of the merger. Duh!

radly

Is this going lower or is it time to buy?

02opida

02opida 23分前

70 out here at the foot of the mountain

Goats'nCrows

Goats'nCrows 23分前

Company is broke.

And I think I can fairly assume you would be willing to add that we longs are about to languish in more silence...waiting on certain death.

So why all the effort if we're really about to get our comeuppance as a result of the ill behavior you attrib

DJ Global exUS Health Care

Kaleido Biosciences (EM)

Andritz AG Graz (PK)

It Now Ibovespa Fundo de...

BMO Premium Yield ETF

Threshold Network Token

Invesco Markets II

Globalink Investment (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。